These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4316389)

  • 1. Converting enzyme in rat serum.
    Loyke HF
    Proc Soc Exp Biol Med; 1970 May; 134(1):248-51. PubMed ID: 4316389
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensins lung converting enzyme.
    Loyke HF
    Proc Soc Exp Biol Med; 1973 May; 143(1):82-4. PubMed ID: 4349977
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatic inactivation and pressor action of angiotensin].
    Wernze H; Fujii J
    Z Gesamte Exp Med Einschl Exp Chir; 1966; 140(2):128-35. PubMed ID: 4293986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relation between the blood-pressure effect of angiotensin II and the mean arterial pressure, serum sodium, serum potassium, serum angiotensinase and plasma renin in man].
    Oelkers W; Langholz HJ; von Goldacker IU
    Z Kreislaufforsch; 1968 May; 57(5):437-45. PubMed ID: 4300463
    [No Abstract]   [Full Text] [Related]  

  • 5. Differentiation of nephrotensin from the renin angiotensin system.
    Susic D; Sparks JC
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):958-61. PubMed ID: 165547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressor response to angiotensins I and II and renin in rats treated with carbon tetrachloride.
    Carretero OA; Bumpus FM; Smeby RR
    Nature; 1969 Mar; 221(5185):1067-8. PubMed ID: 4304486
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on renin-angiotensin system. I. Angiotensinase activities in hepatic disorders].
    Hirasawa K
    Jpn Circ J; 1968 Mar; 32(3):407-15. PubMed ID: 4299837
    [No Abstract]   [Full Text] [Related]  

  • 8. Converting enzyme in CC14-treated renal hypertension.
    Loyke HF
    Am J Physiol; 1968 Dec; 215(6):1334-6. PubMed ID: 4301935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiotensin I-converting enzyme activity; determination methods and current topics].
    Kurihara H
    Saishin Igaku; 1971 Nov; 26(11):2044-53. PubMed ID: 4334937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renin activity, angiotensinogen levels and plasma angiotensinase activity in patients with hypertensive diseases of the kidneys].
    Serebrovskaia IuA; Paleeva FM; Uchitel' IA; Chkalova IP
    Kardiologiia; 1971 Aug; 11(8):92-100. PubMed ID: 4334381
    [No Abstract]   [Full Text] [Related]  

  • 11. The pressor response to serum and exogenous renin in rats.
    Loyke HF
    J Lab Clin Med; 1967 Jun; 69(6):1013-7. PubMed ID: 4290585
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the vasopressor effect and inactivation of angiotensin in essential and renal as well as experimental hypertension].
    Wernze H; Hosoda S; Schölkens B
    Arch Klin Med; 1968; 214(3):286-305. PubMed ID: 4300861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of plasma angiotensinase activity in patients with hypertensive disease and symptomatic renal hypertension].
    Raeva IP
    Kardiologiia; 1967 Sep; 7(9):64-70. PubMed ID: 4305719
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II and renal hypertension in dog, rat and man: effect of converting enzyme inhibition.
    Atkinson AB; Brown JJ; Fraser R; Lever AF; Morton JJ; Riegger AJ; Robertson JI
    Clin Exp Hypertens (1978); 1980; 2(3-4):499-524. PubMed ID: 6253241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collagen peptidase activity in the rat liver in chronic CCl-4 poisoning].
    Hoffmann-Blume E; Fricke RJ; Hahn O
    Z Rheumaforsch; 1973; 32(11):460-7. PubMed ID: 4781873
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of aldosterone in experimental hypertension.
    McCaa RE; McCaa CS; Bengis RG; Guyton AC
    J Endocrinol; 1979 May; 81(2):69P-78P. PubMed ID: 222873
    [No Abstract]   [Full Text] [Related]  

  • 18. Regression of left ventricular hypertrophy by angiotensin converting enzyme inhibitor in reduced renal mass hypertensive rats.
    Nakamura F; Nagano M; Higaki J; Higashimori K; Katahira K; Morishita R; Mikami H; Ogihara T
    J Hypertens Suppl; 1991 Dec; 9(6):S398-9. PubMed ID: 1840202
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma angiotensin I converting enzyme activity in rabbits under various experimental conditions.
    Kurihara H
    Jpn Circ J; 1972 Jun; 36(6):587-8. PubMed ID: 4343890
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIMENTAL HYPERTENSIONS TREATED WITH CCL-4: MEASUREMENTS OF ADRENAL FUNCTION, VASCULAR RESPONSIVENESS, ANGIOTENSINASE AND CONVERTING ENZYME.
    LOYKE HF
    Proc Soc Exp Biol Med; 1964 Apr; 115():1035-40. PubMed ID: 14166553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.